ConductScience.org, home

Trial · NCT01213173

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe Impact on 24-hr Average Heart Rate Between Two Groups (Betaloc ZOK® 95mg vs. 190mg)After 8 weeks treatment in the studyDifference of the 24-hr average heart rate between two groups after 8 weeks treatment.
SecondaryThe Impact on 24-hr Average Heart Rate From Baseline Within GroupsAfter 8 weeks treatment in the studyDifference of the 24-hr average heart rate within groups from baseline after 8 weeks treatment.
SecondaryThe Different Impact on 24-hr Average Heart Rate Between Two GroupsAfter 2 weeks treatment in the studyDifference of the 24-hr average heart rate between two groups after 2 weeks of treatment.
SecondaryThe Different Impact on 24-hr Average Heart Rate From Baseline Within GroupsAfter 2 weeks treatment in the studyDifference of the 24-hr average heart rate within groups from baseline after 2 weeks treatment.
SecondaryThe Proportion of Patients With Resting Heart Rate Controlled to ≤60bpm Between GroupsAfter 2 weeks treatmentDifference in proportions of patients who had resting heart rate controlled to ≤60 bpm after 2 weeks treatment between groups
SecondaryThe Proportion of Patients With Resting Heart Rate Controlled to ≤60bpm Between GroupsAfter 8 weeks treatmentDifference in proportions of patients who had resting heart rate controlled to ≤60 bpm after 8 weeks treatment between groups
SecondaryThe Difference of Change From Baseline in Total Ischemic Burden Between GroupsAfter 2 weeks treatment
Difference in change from baseline in TIB between two groups after 2 weeks treatment. Total Ischemic Burden (TIB) was defined as the sum of product of each ischemia episode lasting time and maximal ST elevation: TIB=Σ(STmax×Tisc).
SecondaryThe Difference of Change From Baseline in Total Ischemic Burden Between GroupsAfter 8 weeks treatment
Difference in change from baseline in TIB between two groups after 8 weeks treatment. Total Ischemic Burden (TIB) was defined as the sum of product of each ischemia episode lasting time and maximal ST elevation: TIB=Σ(STmax×Tisc).
SecondaryThe Difference of Change From Baseline in Angina Frequency Between GroupsAfter 2 weeks treatmentDifference in change from baseline of angina pectoris frequency between two groups after 2 weeks treatment.
SecondaryThe Difference of Change From Baseline in Angina Frequency Between GroupsAfter 8 weeks treatmentDifference in change from baseline of angina pectoris frequency between two groups after 8 weeks treatment.
SecondaryThe Change From Baseline in Total CholesterolAfter 8 weeks treatmentDifference of change from baseline in TC after 8 weeks treatment between groups.
SecondaryThe Change From Baseline in Fasting Plasma GlucoseAfter 8 weeks treatmentDifference of change from baseline in FPG after 8 weeks treatment between groups.
SecondaryThe Change From Baseline in TriglyceridesAfter 8 weeks treatmentDifference of change from baseline in TG after 8 weeks treatment between groups.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01213173/registered